North America Long Read Sequencing Market, By Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing, and Others), Product (Instruments, Consumables, and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing, Identification and fine mapping of structural variation, Tandem Repeat Sequencing, Pseudogene discrimination, Resolving allele phasing, Reproductive genomics, Cancer, Viral and Microbial Sequencing and Others), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), End-user (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities, and Others) – Industry Trends and Forecast to 2030.
North America Long Read Sequencing Market Analysis and Size
The growing awareness for long-read sequencing is also cumulative market value as the sequencing process has proved important in modified medicines. Many research studies are currently being conducted, which are expected to provide a modest lead for producers to mature new and advanced elongated read sequencing and to provide numerous other opportunities in the long read sequencing market.
Data Bridge Market Research analyses that the long read sequencing market, which was USD 515.64 million in 2022, would rocket up to USD 3,305.5 million by 2030 and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
North America Long Read Sequencing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015- 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Single-Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing, and Others), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), End-user (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico
|
|
Market Players Covered
|
Illumina, Inc. (U.S), MicrobesNG (U.S), Roche Sequencing (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S), Oxford Nanopore Technologies plc (U.K), Quantapore, Inc.(U.S), FG Technologies(Switzerland), BaseClearB.V (Netherlands) INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY ( France), The Garvan Institute (Australia), Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Long-read sequencing, often known as third-generation sequencing, is a technique for analyzing large amounts of data. This is a technology in which DNA particles are sequenced right in real-time, and since this straight sequencing, long reads are produced. These sequencing reactions are approved without the use of PCR amplification often. Long-read sequencing includes two techniques: single molecule real-time (SMRT) sequencing and nanopore sequencing.
North America Long Read Sequencing Market Dynamics
Drivers
- The surge in incidences of genetic disorders
The mounting number of entities facing genetic disorders would help grow the market in the coming years. According to the Centers for Disease Control and Prevention, there are approximately 100,000 people in the United States who have sickle cell disease. The advancement of patients will draw the attention of many key companies to bring up keys, which is expected to propel the market's growth.
- Rising utilization of sequence analysis methodologies
The increasing acceptance of modern medical diagnostics approaches represents one of the key factors bolstering market growth. The growing popularity of LRS technology is also due to its portability and real-time speed. It is also used to create an accurate reference map of the chromosome centromeres. Aside from that, several biotech firms are developing novel technologies that combine a new library prep method with genome analysis tools. Several studies show that LRS technology is critical for identifying novel pathogenic mutations in human diseases with unknown genetic causes. This opens up numerous opportunities for researchers to apply the technology in whole-genome sequencing (WGS), allowing medical genetics to advance.
Opportunities
- Rising use of long-read sequencing
Long-read sequencing has many advantages over short- or second-generation sequencing techniques, fuelling market growth even further. For example, Long reads generated by single-molecule real-time sequencing (SMRT) provide a comprehensive overview of the entire genome and are used for different genetic and structural variants. Researchers estimated in 2015 that long-read sequencing could be used to assemble dozens of bacterial and viral genomes. Aside from that, rising awareness of long-read sequencing and increased investments in R&D activities drive market growth.
Restraints/Challenges
- Higher cost per base relative to short-read sequencing
Long-read sequencing market is facing trials due to the lack of highly cutting-edge genomic testing centers, expensive installation processes, and the absence of experts specific with progressive diagnostic abilities.
This long read sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the long read sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2019, Flongle was developed by Oxford Nanopore to quickly analyse short DNA/RNA sequences. Flongle is an adaptor for GridION X5 desktop and MinION portable sequencing techniques. Small Flange cells with a capacity of up to 1.8 Gb of sequence data and headroom for up to 3 Gb. This merchandise promotion will aid in the consolidation of the company's product portfolio.
- In February 2020, Promega Corporation launched the Wizard HMW DNA Extraction Kit for scientists working with large genomic DNA fragments. In a 90-minute protocol, researchers can obtain DNA fragments that will improve performance in long read sequencing applications using this kit. As a result, the company's product portfolio has become more appealing, appealing, and advanced.
North America Long Read Sequencing Market Scope
The long read sequencing market is segmented on the basis of technology, product, workflow, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Nanopore Sequencing
- Single Molecule Real Time Sequencing (SMRT)
Product
- Consumables
- Instruments
- Services
Workflow
- Sequencing
- Data Analysis
- Pre-Sequencing
Application
- Whole Genome Sequencing
- Epigenetics
- RNA Sequencing
- Complex Population
- Tandem Repeat Sequencing
- Identification and fine mapping of structural variation
- Viral and Microbial Sequencing
- Reproductive genomics
- Pseudogene discrimination
- Others
End User
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Industry
- Other
Long Read Sequencing Market Regional Analysis/Insights
The long read sequencing market is analysed and market size insights and trends are provided by country, technology, product, workflow, application and end-user as referenced above.
The countries covered in the long read sequencing market report are U.S., Canada and Mexico in North America.
U.S. is dominating the long read sequencing market because of the large number of companies, R&D capabilities, and development in the long read sequencing market during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Long Read Sequencing Market Share Analysis
The long read sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to long read sequencing market.
Some of the major players operating in the long read sequencing market are:
- Illumina, Inc. (U.S)
- MicrobesNG (U.S)
- Roche Sequencing (U.S)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- PacBio (U.S)
- Oxford Nanopore Technologies plc (U.K)
- Quantapore, Inc. (U.S)
- FG Technologies (Switzerland)
- BaseClear B.V(Netherlands)
- INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France)
- The Garvan Institute (Australia)
- France Génomique (France)
- Takara Holdings Inc. (Japan)
- Genexa AG (Switzerland)
SKU-